Onténiente B, Horellou P, Neveu I, Makeh I, Suzuki F, Bourdet C, Grimber G, Colin P, Brachet P, Mallet J
INSERM CJF 91-02, UFR de Médecine 8, Créteil, France.
Brain Res Mol Brain Res. 1994 Feb;21(3-4):225-34. doi: 10.1016/0169-328x(94)90253-4.
A mouse line transgenic for nerve growth factor (NGF) was developed using the mouse prepro-NGF cDNA inserted within a plasmid containing the proximal region (-10 to -550 bp) of the c-fos promoter and the transcription termination and polyadenylation signals of the rabbit beta-globin gene. No significant modification of gross behavior or central nervous system anatomy was detected in adult animals as assessed by immunohistochemistry and in situ hybridization for NGF and choline acetyltransferase. The expression of the transgene and the possible regulation of its expression by agents acting on the promoter were investigated in vitro. Despite the presence of an additional pool of NGF mRNA specific to the transgene, basal levels of NGF in the supernatant of transgenic astrocytes were similar to normal ones. On the other hand, transgenic neurons spontaneously synthesized and released levels of NGF two to three times higher than normal neurons, while mRNA levels were barely detectable by conventional Northern blotting. The tissue-specificity of NGF expression was respected, with higher levels in hippocampal than neocortical neurons. Increases of NGF mRNA by agents acting on the promoter could be observed in normal and transgenic astrocytes only after inhibition of the protein synthesis by cycloheximide, suggesting a similar rapid turnover of normal and transgenic transcripts. Cyclic AMP agonists specifically increased the secretion of NGF protein by transgenic astrocytes and neurons, while activators of the protein kinase C had a similar effect on transgenic and normal cells. Differences between amounts of NGF secreted by neurons and astrocytes with regards to their respective content in mRNA suggest that transgenic transcripts are subject to normal cell- and tissue-specific post-transcriptional regulations. Agents acting on the c-fos promoter through the protein kinase C or cyclic AMP routes differentially increased the secretion of NGF by transgenic astrocytes or neurons, supporting this hypothesis.
利用插入含有c-fos启动子近端区域(-10至-550 bp)以及兔β-珠蛋白基因转录终止和聚腺苷酸化信号的质粒中的小鼠前体神经生长因子(NGF)cDNA,培育出了一种神经生长因子转基因小鼠品系。通过对NGF和胆碱乙酰转移酶进行免疫组织化学和原位杂交评估,未在成年动物中检测到总体行为或中枢神经系统解剖结构的显著改变。在体外研究了转基因的表达及其受作用于启动子的因子调控的可能性。尽管存在转基因特有的另一池NGF mRNA,但转基因星形胶质细胞上清液中NGF的基础水平与正常细胞相似。另一方面,转基因神经元自发合成和释放的NGF水平比正常神经元高两到三倍,而通过传统的Northern印迹法几乎检测不到mRNA水平。NGF表达具有组织特异性,海马神经元中的水平高于新皮质神经元。只有在用环己酰亚胺抑制蛋白质合成后,才能在正常和转基因星形胶质细胞中观察到作用于启动子的因子使NGF mRNA增加,这表明正常和转基因转录本的周转速度相似。环磷酸腺苷激动剂特异性增加转基因星形胶质细胞和神经元分泌NGF蛋白,而蛋白激酶C激活剂对转基因细胞和正常细胞有类似作用。神经元和星形胶质细胞分泌的NGF量与其mRNA各自含量之间的差异表明,转基因转录本受到正常的细胞和组织特异性转录后调控。通过蛋白激酶C或环磷酸腺苷途径作用于c-fos启动子的因子,对转基因星形胶质细胞或神经元分泌NGF的增加有不同影响,支持了这一假说。